Canale-Theakston Carin
Cidara Therapeutics, Inc. · Director
Canale-Theakston Carin is listed in public filings as director. This Canale-Theakston Carin insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Cidara Therapeutics, Inc. (CDTX). Investors use Canale-Theakston Carin's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $016k shares | OtherJan 7, 2026 | $365.0K16k shares | $22.81 | -- | |
| $011.1k shares | OtherJan 7, 2026 | $236.5K11.1k shares | $21.31 | -- | |
| $01.8k shares | OtherJan 7, 2026 | $87.8K1.8k shares | $50.20 | -- | |
| $02.1k shares | OtherJan 7, 2026 | $49.7K2.1k shares | $23.40 | -- | |
| $0875 shares | OtherJan 7, 2026 | $33.6K875 shares | $38.40 | -- | |
| $02.1k shares | OtherJan 7, 2026 | $26.9K2.1k shares | $12.64 | -- | |
| $01.4k shares | OtherJan 7, 2026 | $14.8K1.4k shares | $10.60 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $237k11.1k shares | Grant / ExerciseJun 18, 2025 | $236.5K11.1k shares | $21.31 | -- | |
| $365k16k shares | Grant / ExerciseDec 17, 2024 | $365.0K16k shares | $22.81 | -- | |
| $27k2.1k shares | Grant / ExerciseJul 18, 2024 | $26.9K2.1k shares | $12.64 | -- |